Data / Form D filings / Evofem Biosciences, Inc.
Evofem Biosciences, Inc.: Form D filings
Evofem Biosciences, Inc., a biotechnology company in San Diego, CA, filed 11 Form D notices with the SEC between 2019 and 2025. The latest, on July 2, 2025, reports $925,000 sold of a $925,000 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7770 REGENTS ROAD, SUITE 113-618, San Diego, CA, 92122
- Phone
- (858) 550-1900
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1618835
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 2, 2025 | New notice | $925,000 | $925,000 | 1 | Jun 26, 2025 | sec.gov | |
| Apr 15, 2025 | New notice | $1,500,000 | $750,000 | $750,000 | 1 | Apr 8, 2025 | sec.gov |
| Aug 21, 2024 | New notice | $500,000 | $500,000 | 1 | Aug 9, 2024 | sec.gov | |
| Aug 21, 2024 | New notice | $500,000 | $500,000 | 1 | Jul 12, 2024 | sec.gov | |
| Oct 11, 2023 | New notice | $2,884,615 | $2,884,615 | 14 | Sep 27, 2023 | sec.gov | |
| Mar 6, 2023 | New notice | $1,384,616 | $1,384,616 | 4 | Feb 17, 2023 | sec.gov | |
| Feb 3, 2023 | New notice | $2,307,693 | $2,307,693 | 8 | Dec 20, 2022 | sec.gov | |
| Oct 16, 2020 | New notice | $25,000,000 | $25,000,000 | 2 | Oct 14, 2020 | sec.gov | |
| May 6, 2020 | New notice | $25,000,000 | $15,000,000 | $10,000,000 | 2 | Apr 24, 2020 | sec.gov |
| Apr 22, 2019 | New notice | $80,000,000 | $30,000,001 | $49,999,999 | 1 | Apr 11, 2019 | sec.gov |
| Feb 14, 2019 | New notice | $12,500,000 | $6,300,000 | $6,200,000 | 5 | Feb 8, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Colin Rutherford | Director | |
| Ivy Zhang | Executive Officer | |
| Kim Kamdar | Director | |
| Lisa Rarick | Director | |
| Saundra Pelletier | Executive Officer, Director | |
| Tony O'Brien | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jun 30, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Evofem Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.